郭学武

• 1:洛宁县人民医院

摘要(Abstract)：

目的探究急性心肌梗死合并脑血管病的预后。方法将洛宁县人民医院门诊2011-06—2016-06收治的100例急性心肌梗死合并脑血管病患者,按治疗方式不同将患者分为观察组(常规治疗辅助心脑舒通片治疗)和对照组(常规治疗),各50例,根据后续观察和随访结果比较2组患者疗效、心肌梗死和脑梗死的发病率情况。结果观察组总显效率(88.0%)显著高于对照组(60.0%),差异具有统计学意义(P<0.05);观察组中3例发生心肌梗死,2例发生脑梗死;对照组中9例发生心肌梗死,6例发生脑梗死。观察组心肌梗死和脑梗死发病率(10.0%)显著低于对照组(30.0%),差异具有统计学意义(P<0.05)。结论常规治疗辅助心脑舒通片对急性心肌梗死合并脑血管病疗效显著,能显著降低心肌梗死和脑梗死的发病率,值得在临床上广泛推广。

关键词(KeyWords)： 急性心肌梗死;脑血管病;脑梗死;预后

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 郭学武

参考文献(References)：

• [1] 薛雅瑜,徐琼英.优化急诊护理流程对急性心肌梗死患者救治效果及预后的影响[J].现代中西医结合杂志,2015,21(32):3 637-3 638.
• [2] 高晓津,杨进刚,杨跃进,等.中国急性心肌梗死患者心血管危险因素分析[J].中国循环杂志,2015,30(3):206-210.
• [3] 王艳英,鞠智卿,黄贤胜.不同院前急救方式对急性心肌梗死合并急性左心衰竭救治效果及预后影响研究[J].河北医学,2015,21(8):1 487-1 490.
• [4] 裘丽红,韩新生,苏建,等.老年缺血性脑血管病患者的临床特点分析[J].中华老年心脑血管病杂志,2014,16(6):613-616.
• [5] 徐恩,温海霞.脑血管病危险因素及其干预管理[J].中国现代神经疾病杂志,2015,15(1):20-26.
• [6] 徐志云.胺碘酮治疗心肌梗死合并室性心律失常的疗效及其对C反应蛋白的影响[J].中西医结合心脑血管病杂志,2016,14(22):2 661-2 663.
• [7] 巧丽番·阿力哈孜,迪丽努尔·买买提依明,木胡牙提.昼夜血压节律对急性心肌梗死合并高血压患者再发心脑血管事件的影响[J].中国临床保健杂志,2015,18(1):1-4.
• [8] 宋俊贤,陈红.急性心肌梗死早期救治和预后的时间节律性[J].中华老年心脑血管病杂志,2016,18(8):876-879.
• [9] GATTRINGER T,NIEDERKOR N K,SEYFANG L,et al.Myocardial infarction as a complication in acute stroke:Results from the austrian stroke unit registry[J].Cerebrovasc Dis,2014,37(2):147-152.
• [10] KOTON S,GERBER Y,GOLDBOUR T U,et al.Socioeconomic risk factor aggregation and long-term incidence of ischemic stroke in patients after first acute myocardial infarction[J].IntJCardiol,2012,157(3):324-329.
• [11] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会,中国学会杂志编辑委员会.急性心肌梗死诊断和治疗指南[J].中国循环杂志,2001,16(6):1 067-1 068.
• [12] 中华神经科学会,中华神经外科学会.脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383.
• [13] BRAMM?S A,JAKOBSSONS,ULVENSTAMA,et al.Mortality after ischemic stroke in patients with acute myocardial infarction:Predictors and trends over time in Sweden[J].Stroke,2013,44(11):3 050-3 055.
• [14] HUYNH T,GAGNON R,IFTIKHAR U,et al.RECURRENT ISCHEMIC CARDIO/CEREBROVASCULAR EVENTS AMONG PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION:INSIGHTS FROM THE AMI-QUEBEC REGISTRY[J].J Am Coll Cardiol,2016,67(13):483-483.
• [15] ZHONG C,YOU S,ZHONG X,et al.Retinal vein occlusion and risk of cerebrovascular disease and myocardial infarction:A meta-analysis of cohort studies.[J].Atherosclerosis,2016,247:170-176.
• [16] PAIOCCHIVL,MARCONS,LEO LA,et al.P844Revisited role of Q-waves ECG in myocardial scar identification in patients with prior myocardial infarction[J].Eur Heart J,2017,38 (suppl_1).
• [17] ZEYMER U,HOCHADEL M,LAUER B,et al.Use,efficacy and safety of prasugrel in patients with ST segment elevation myocardial infarction scheduled for primary percutaneous coronary intervention in clinical practice.Results of the prospective ATACS-Registry[J].Int J Cardiol,2015,184:122.
• [18] KIM H S,LEE H J,KIM K Y,et al.The General Public’s Awareness of Early Symptoms of and Emergency Responses to Acute Myocardial Infarction and Related Factors in South Korea:A National Public Telephone Survey[J].J Epidemiol,2016,138(3):275-280.
• [19] ZHOUEH,GELPERINK,LEVENSONMS,et al.Risk of acute myocardial infarction,stroke,or death in patients initiating olmesartan or other angiotensin receptor blockers-a cohort study using the clinical practice research datalink[J].Pharmacoepidem D S R,2014,23(4):340-347.
• [20] 杨菊,刘西平,沈长银,等.缺血后适应对急性心肌梗死患者临床及预后的影响[J].中华老年心脑血管病杂志,2014,16(6):584-587.
• [21] 施展,郭治平.心脑舒通胶囊治疗心肌梗死伴慢性心功能不全41例临床观察[J].中西医结合心脑血管病杂志,2013,11(11):1 310-1 311.
• [22] 傅祥坤.心脑舒通片治疗脑血栓形成24例临床观察[J].长春中医药大学学报,2013,29(3):479-479.
• [23] 吴以岭,魏聪.通络药物治疗心脑血管病现状与展望[J].疑难病杂志,2015,14 (1):1-5.
• [24] 闫薇薇,艾清,秦玲,等.心脑舒通胶囊治疗冠心病心绞痛有效性及安全性的Meta分析[J].中国中医急症,2016,25(9):1 690-1 692.
• [25] 王金鑫,卢国彦,郭虹,等.心脑舒通胶囊对蒙古沙鼠全脑缺血再灌注损伤模型的神经保护作用[J].中国临床药理学杂志,2017,33(6):518-521.
• [26] 张娜,栾晓莹,谢燕,等.HPLC-ELSD测定心脑舒通胶囊中Terrestrinin A的含量[J].天津中医药大学学报,2017,36(2):132-135.
• [27] 卜迟文,杨全德,张冬,等.心脑舒通胶囊联合瑞舒伐他汀对高血脂症患者炎症因子及血管内皮功能的影响[J].现代中西医结合杂志,2018,27(18):1 975-1 978.
• [28] 郭尧树,李宇青,黄林升.心脑舒通胶囊合左卡尼丁注射液治疗冠心病心绞痛50例[J].中西医结合心脑血管病杂志,2013,11(8):994-995.
• [29] 李淑梅,杨兴义,毛莉,等.心脑舒通片辅助治疗2型糖尿病合并颈动脉斑块老年患者的临床疗效观察[J].世界临床药物,2016,37(5):319-323.
• [30] CHRISTERSSON C,LINDAHL B,BERGLUND L,et al.The utility of coagulation activity for prediction of risk of mortality and cardiovascular events in guideline-treated myocardial infarction patients[J].Ups J Med Sci,2017,122(4):224-233.
• [31] NASER N,KULIC M,DILIC M,et al.The Cumulative Incidence of Stroke,Myocardial infarction,Heart Failure and Sudden Cardiac Death in Patients with Atrial Fibrillation[J].Med Arch,2017,71(5):316-319.
• [32] BRAVATA D M,DAGGY J,BROSCH J,et al.Comparison of Risk Factor Control in the Year After Discharge for Ischemic Stroke Versus Acute Myocardial Infarction[J].Stroke,2018,49(2):296-303.
• [33] CEDIEL G,RUEDA F,GARCíA C,et al.Prognostic Value of New-Generation Troponins in ST-Segment-Elevation Myocardial Infarction in the Modern Era:The RUTI-STEMI Study[J].J Am Heart Assoc,2017,6(12).pii:e007252.10.1161/JAHA.117.007252.PubMed PMID:29275366;PubMed Central PMCID:PMC5779038.
• [34] ZHOU X,SHRESTHA S S,LUMAN E,et al.Medical Expenditures Associated With Diabetes in Myocardial Infarction and Ischemic Stroke Patients[J].Am J Prev Med,2017,53(6S2):S190-S196.
• [35] KOLTE D,SARDAR P,KHERA S,et al.Culprit Vessel-Only Versus Multivessel Percutaneous CoronaryIntervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction:A Collaborative Meta-Analysis[J].Circ Cardiovasc Interv,2017,10(11).pii:e005582.
• [36] JOLIAT G R,HALKIC N,PANTET O,et al.Ischemic stroke and ST-elevation myocardial infarction revealing infective endocarditis[J].Eur Rev Med Pharmacol Sci,2017,21(20):4 640-4 641.
• [37] ISHIKAWA S,NOMA T,FU H Y,et al.Apoptosis inhibitor of macrophage depletion decreased M1 macrophage accumulation and the incidence of cardiac rupture after myocardial infarction in mice[J].PLoS One,2017,12(11):e0187894.
• [38] FANOLA C L,MORROW D A,CANNON C P,et al.Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome:Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) Trial[J].J Am Heart Assoc,2017,6(10).pii:e005637.
• [39] DHAMOON M S,LONGSTRETH W T JR,BARTZ T M,et al.Disability Trajectories Before and After Stroke and Myocardial Infarction:The Cardiovascular Health Study[J].JAMA Neurol,2017,74(12):1 439-1 445.
• [40] GE J,SCH?FER A,ERTL G,et al.Thrombus Aspiration for ST-Segment-Elevation Myocardial Infarction in Modern Era:Still an Issue of Debate?[J].Circ Cardiovasc Interv,2017,10(10).pii:e005739.
• [41] SINGH J A,RAMACHANDARAN R,YU S,et al.Is gout a risk equivalent to diabetes for stroke and myocardial infarction?A retrospective claims database study[J].Arthritis Res Ther,2017,19(1):228.
• [42] KERNAN W N,VISCOLI C M,DEARBORN J L,et al.Insulin Resistance Intervention After Stroke (IRIS) Trial Investigators.Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction[J].JAMA Neurol,2017,74(11):1 319-1 327.
• [43] DAHLGREN C,GEARY L,HASSELSTR?M J,et al.Recording a diagnosis of stroke,transient ischaemic attack or myocardial infarction in primary healthcare and the association with dispensation of secondary preventive medication:a registry-based prospective cohort study[J].BMJ Open,2017,7(9):e015723.
• [44] WANG H B,JI P,ZHAO X S,et al.Recombinant human TNK tissue-type plasminogen activator (rhTNK-tPA) versus alteplase (rt-PA) as fibrinolytic therapy for acute ST-segment elevation myocardial infarction (China TNK STEMI):protocol for a randomised,controlled,non-inferiority trial[J].BMJ Open,2017,7(9):e016838.
• [45] YEO K K,ZHENG H,CHOW K Y,et al.Comparative analysis of recurrent events after presentation with an index myocardial infarction or ischaemic stroke[J].Eur Heart J Qual Care Clin Outcomes,2017,3(3):234-242.
• [46] WANG Q,MA J,JIANG Z,et al.Association of lymphocyte-to-monocyte ratio with in-hospital and long-term major adverse cardiac and cerebrovascular events in patients with ST-elevated myocardial infarction[J].Medicine (Baltimore),2017,96(34):e7897.
• [47] YEE J,KUMAR V,PHAM A,et al.Simultaneous Onset of Deep Vein Thrombosis,Pulmonary Embolism,Cerebral Infarction,and Myocardial Infarction in a Patient with Patent Foramen Ovale[J].S D Med,2017,70(6):266-269.
• [48] CHEN P P,LOU P A,ZHANG P,et al.Trend analysis on the death rate of ischemic heart disease and cerebrovascular disease among Xuzhou residents from 2011 to 2015[J].Zhonghua Xin Xue Guan Bing Za Zhi,2017,45(7):597-607.
• [49] SHEN Q N,WANG D X,ZHAI H B,et al.Impact of gender and age on in-hospital major adverse cardiovascular and cerebrovascular events of patients with acute ST-segment elevation myocardial infarction[J].Zhonghua Xin Xue Guan Bing Za Zhi,2017,45(4):288-293.
• [50] DAI Y,YANG J,GAO Z,et al.CAMI Registry study group.Atrial fibrillation in patients hospitalized withacute myocardial infarction:analysis of the china acute myocardial infarction (CAMI) registry[J].BMC Cardiovasc Disord,2017,17(1):2.
• [51] KURKOWSKA-JASTRZEBSKA I,KARLINSKI MA,B?AZEJEWSKA-HYZOREK B,et al.Carotid intima media thickness and blood biomarkers of atherosclerosis in patients after stroke or myocardial infarction[J].Croat Med J,2016,57(6):548-557.
• [52] MUSCOGIURI G,ANNWEILER C,DUVAL G,et al.Vitamin D and cardiovascular disease:From atherosclerosis to myocardial infarction and stroke[J].Int J Cardiol,2017,230:577-584.
• [53] CARRERO J J,VARENHORST C,JENSEVIK K,et al.Long-term versus short-term dual antiplatelettherapy was similarly associated with a lower risk of death,stroke,or infarction in patients with acute coronary syndrome regardless of underlying kidney disease[J].Kidney Int,2017,91(1):216-226.
• [54] CRANS YOON A M,CHIU V,RANA J S,et al.Association of allergic rhinitis,coronary heart disease,cerebrovascular disease,and all-cause mortality[J].Ann Allergy Asthma Immunol,2016,117(4):359-364.
• [55] BONACA M P,GOTO S,BHATT D L,et al.Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction:Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54)[J].Circulation,2016,134(12):861-871.
• [56] HIRA R S,COWART J B,AKEROYD J M,et al.Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease[J].Am J Cardiol,2016,118(8):1 144-1 149.
• [57] ELGENDY I Y,MAHMOUD A N,MANSOOR H,et al.Evolution of acute ischemic stroke therapy from lysis to thrombectomy:Similar or different to acute myocardial infarction?[J].Int J Cardiol,2016,222:441-447.
• [58] VISSERS L E,WALLER M A,VAN DER SCHOUW Y T,et al.The relationship between the dietary inflammatory index and risk of total cardiovascular disease,ischemic heart disease and cerebrovascular disease:Findings from an Australian population-based prospective cohort study of women[J].Atherosclerosis,2016,253:164-170.
• [59] AMBROSINO P,LUPOLI R,DI MINNO A,et al.The risk of coronary artery disease and cerebrovascular disease in patients with hepatitis C:A systematic review and meta-analysis[J].Int J Cardiol,2016,221:746-754.
• [60] EKSTR?M K,L?NNBERG A,ANTTONEN O.Myocardial infarction in a patient free of coronary artery disease[J].Duodecim,2016,132(11):1 069-1 073.
• [61] ROST N S,GIUGLIANO R P,RUFF C T,et al.ENGAGE AF-TIMI 48 Investigators.Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events:Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).Stroke,2016,47(8):2 075-2 082.
• [62] GIROLAMI A,SILVIA F,ELISABETTA C,et al.Ischemic Strokes in Congenital Bleeding Disorders:Comparison with Myocardial Infarction and other Acute Coronary Syndromes[J].Cardiovasc Hematol Disord Drug Targets,2016,16(1):6-12.